Patent · US Revoked

Fullerene therapies for inflammation

US8563585B2 · kind B2 · utility

0Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 3, 2009
Grant dateOct 22, 2013
Priority date
Expiry dateJan 26, 2030

Classification

  • Technology area (CPC —)General

Abstract

Described herein are methods for treating inflammatory disorders. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified fullerene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.